Search Results 561-570 of 17915 for testosterone
Serum testosterone < 50 ng/dL. Patients must continue primary ADT with an LHRH analogue (agonist or antagonist) if they have not undergone orchiectomy. Able ...
Prostate gland · Testosterone and prostate cancer · Transrectal biopsy of the prostate · Types of prostate cancer: Common and rare forms · What is prostate ...
Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-alpha ratio and attenuating T-cell infiltration ...
Use of medications known to impact bone and mineral metabolism (e.g., bisphosphonates, corticosteroids, estrogens, testosterone therapy, calcitonin, thyroid ...
Prostate cancer: Does PSA level affect prognosis? Prostate gland · Testosterone and prostate cancer · Transrectal biopsy of the prostate · Types of prostate ...
... testosterone level ≤ 1.73 nmol/l (50 ng/dL) at screening visit. Individuals who have not had a bilateral orchiectomy must have a plan to maintain effective ...
Patients identified with secondary causes for erythrocytosis, including those who are using testosterone therapy or are active smokers with smoking identified ...
Hepatic Adenomatosis in a Transgender Man on Gender-Affirming Testosterone Therapy. ACG Case Rep J. 2024 Sep; 11 (9):e01483 Epub 2024 Sept 11. View PubMed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.